Diclofenac (Itami®)

Assessment Status Rapid Review Complete
Drug Diclofenac
Brand Itami®
Indication For the local symptomatic and short-term treatment (max. 7 days) of pain in acute strains, sprains or bruises of the extremities following blunt trauma e.g. sports injuries in adolescents aged from 16 years and adults
Assessment Process
Rapid review commissioned 31/12/2018
Rapid review completed 17/01/2019
Rapid review outcome A full HTA is not recommended. The NCPE recommends that diclofenac 140mg Medicated Plaster (Itami®) not be considered for reimbursement.  This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.